Role of Xenobiotic Metabolism

Rawlins MD Clinical pharmacology. Adverse reactions to drugs. Br Med J 1981; 282: 974-6.

Denham MJ Adverse drug reactions. Br Med Bull 1990; 46: 53-62.

Hess E. Drug-related lupus. New Engl J Med 1988; 318: 1460-2.

Totoritis MC , Tan EM , McNally EM , Rubin RL Association of antibody to histone complex H2A-H2B with symptomatic procainamide-induced lupus. New Engl J Med 1988; 318: 1431-6.

Burlingame RW , Rubin RL Drug-induced anti-histone autoantibodies display two patterns of reactivity with substructures of chromatin. J Clin Invest 1991; 88: 680-90.

Woodhouse KW , James Ofw. Hepatic drug metabolism and ageing. Br Med Bull 1990; 46: 22-35.

Hein DW , Weber WW Metabolism of procainamide, hydralazine and isoniazid in relation to autoimmune(-like) reactions. In: Autoiminunity and Toxicology. Kammueller ME , Bloksma N , Seinen W (eds). Amsterdam: Elsevier Science, 1989 : 239-65.

Babior BM Oxygen-dependent microbial killing by phagocytes. New Engl J Med 1978; 298: 659-68.

Rubin RL , Curmutte JT Metabolism of procainamide to the cytotoxic hydroxylamine by neutrophils activated in vitro. J Clin Invest 1989; 83: 1336-43.

Waldhauser L. , Uetrecht J. Oxidation of propylthiouracil to reactive metabolites by activated neutrophils. Implications for agranulocytosis. Drug Metab Dispos 1991; 19: 354-9.

Hofstra AH , Matassa LC , Uetrecht JP Metabolism of hydralazine by activated leukocytes: implications for hydralazine-induced lupus. J Rheumatol 1991; 18: 1673-80.

Kelder PP , De Moal MJ , 't Hart BA , Janssen Lhm. Metabolic activation of chlorpromazine by stimulated human polymorphonuclear leukocytes. Induction of covalent binding of chlorpromazine to nucleic acids and proteins. Chem Biol Interact 1991; 79: 15-30.

Hofstra AH , Li-Muller Sma , Uetrecht JP Metabolism of isoniazid by activated leukocytes. Possible role in drug-induced lupus. Drug Metab Dispos 1992; 20: 206-10.

Jiang X. , Khursigara G. , Rubin RL Transformation of lupus-inducing drugs to cytotoxic products by activated neutrophils Science (in press).

Uetrecht JP Reactivity and possible significance of hydroxylamine and nitroso metabolites of procainamide. J Pharmacol Exp Ther 1985 ; 232:420-5.

Roberts SM , Adams LE , Donovan-Brand R. et al. Procainamide hydroxylamine lymphocyte toxicity 1. Evidence for participation by hemoglobin. Int J Immunopharmacol 1989; 11: 419-27.

Rubin RL , Uetrecht JP , Jones JE Cytotoxicity of oxidative metabolites of procainamide. J Pharmacol Exp Ther 1987; 242: 833-41.

Adams LE , Sanders CE , Jr, Budinsky RA , Donovan-Brand R. , Roberts SM , Hess EV Immunomodularity effects of procainamide metabolites: their implications in drug-related lupus. J Lab Clin Med 1989; 113: 482-92.